Webster A - Search Results

1

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.

Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A. Mäkelä MJ, et al. Among authors: webster a. J Infect. 2000 Jan;40(1):42-8. doi: 10.1053/jinf.1999.0602. J Infect. 2000. PMID: 10762110 Clinical Trial.

2

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.

Monto AS, Webster A, Keene O. Monto AS, et al. Among authors: webster a. J Antimicrob Chemother. 1999 Nov;44 Suppl B:23-9. doi: 10.1093/jac/44.suppl_2.23. J Antimicrob Chemother. 1999. PMID: 10877459 Clinical Trial.

3

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

Zambon M, Hays J, Webster A, Newman R, Keene O. Zambon M, et al. Among authors: webster a. Arch Intern Med. 2001 Sep 24;161(17):2116-22. doi: 10.1001/archinte.161.17.2116. Arch Intern Med. 2001. PMID: 11570941 Clinical Trial.

4

Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers.

Webster A, Boyce M, Edmundson S, Miller I. Webster A, et al. Clin Pharmacokinet. 1999;36 Suppl 1:51-8. doi: 10.2165/00003088-199936001-00006. Clin Pharmacokinet. 1999. PMID: 10429840 Clinical Trial.

5

Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.

Gravenstein S, Johnston SL, Loeschel E, Webster A. Gravenstein S, et al. Among authors: webster a. Drug Saf. 2001;24(15):1113-25. doi: 10.2165/00002018-200124150-00003. Drug Saf. 2001. PMID: 11772145 Review.

6

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr. Francis CW, et al. Among authors: webster ak. Ann Intern Med. 2002 Oct 15;137(8):648-55. doi: 10.7326/0003-4819-137-8-200210150-00008. Ann Intern Med. 2002. PMID: 12379064 Clinical Trial.

7

RP9 revisited; RP9 p.(H137L) remains a likely cause of dominant splicing factor-Retinitis Pigmentosa.

Chang L, Poulter JA, Webster AR, Arno G, Mukherjee R, Lotery A, Hardcastle AJ, Watson CM, Inglehearn CF. Chang L, et al. Among authors: webster ar. Eur J Hum Genet. 2025 Oct 23. doi: 10.1038/s41431-025-01964-0. Online ahead of print. Eur J Hum Genet. 2025. PMID: 41131384

8

Implementation context of outpatient physical therapy clinics preparing to launch a new evidence-based clinical program for knee osteoarthritis: Findings from a national multisite implementation trial.

Drake C, Webb S, Anderson L, Cummin G, Tucker M, Webster A, Sperber N, Coffman CJ, FullenKamp NK, Zullig LL, Hughes JM, Hastings SN, Van Houtven CH, Abbate LM, Hoenig H, Ballengee LA, Allen KD. Drake C, et al. Among authors: webster a. Arch Phys Med Rehabil. 2025 Oct 12:S0003-9993(25)00971-2. doi: 10.1016/j.apmr.2025.09.032. Online ahead of print. Arch Phys Med Rehabil. 2025. PMID: 41086897

9

A novel missense TUBB4B variant outside of the canonical hotspot is associated with cone-rod dystrophy and sensorineural hearing loss.

Cao LY, Duemler A, Jung EH, Maldonado RS, Richards S, Schiff ER, Mahroo OA, Webster AR, Lin S, Fenner BJ, Iannaccone A, Alekseev O. Cao LY, et al. Among authors: webster ar. Ophthalmic Genet. 2025 Oct 7:1-10. doi: 10.1080/13816810.2025.2565651. Online ahead of print. Ophthalmic Genet. 2025. PMID: 41057290

10

Underlying Diagnosis and RBC transfusions increase HLA antibodies in children before hematopoietic stem cell transplant.

Ashraf A, Murphey C, Sper C, Webster A, Lane A, Mesa S, Garcia F, Perez R, Chamblin C, Davies SM, Khandelwal P. Ashraf A, et al. Among authors: webster a. Transplant Cell Ther. 2025 Oct 1:S2666-6367(25)01478-2. doi: 10.1016/j.jtct.2025.09.046. Online ahead of print. Transplant Cell Ther. 2025. PMID: 41043775 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,850 results

Search Page

Filters